Journals / Journal of Neurological Sciences (Turkish) / 2009 / Cilt: 26 - Sayı: 3

Gerilim tipi baş ağrısı olan anemili hastalar ile huzursuz bacak sendromu birlikteliğinin araştırılması

The relationship between tension-type headache patients with anemia and restless-leg syndrome

Pages
305–310
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The alterations in iron metabolism can be a facilitating factor for appearing of RLS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study was to investigate the prevalence of restless-leg syndrome (RLS), widespread of the RLS symptoms, effect of sypmtoms and applied therapies in tension-type headache patients with anemia due to iron deficiency and vitamin B12 deficiency.
📊
Key Findings & Data:We also examined the effects of ferritin in RLS.Material and methods: We evaluated 56 tension-type headache patients from our headache clinic.
💡
Conclusion & Impact:The alterations in iron metabolism can be a facilitating factor for appearing of RLS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of the study was to investigate the prevalence of restless-leg syndrome (RLS), widespread of the RLS symptoms, effect of sypmtoms and applied therapies in tension-type headache patients with anemia due to iron deficiency and vitamin B12 deficiency. We also examined the effects of ferritin in RLS.Material and methods: We evaluated 56 tension-type headache patients from our headache clinic. In the patient group; 32 patients had iron deficiency, 24 patients had megaloblastic anemia caused by vitamin B12 deficiency. 20 control subjects with tension-type headache were included to the study. Control group subjects did not have anemia. Control and patient group were evaluated according to RLS diagnostic criteria.Results: The prevalence fo RLS was 12.5% in iron deficiency anemia, 8.03% in megaloblastic anemia, 5% in control group, respectively. The incidence of RLS was 7.7% in all patient and control group.Conclusion: RLS is especially seen in female and older age. The alterations in iron metabolism can be a facilitating factor for appearing of RLS.

Özet

Amaç: gerilim tipi başağrısı olan demir eksikliği anemili(DEA) ve B12 vitamin eksikliğine bağlı megaloblastik anemili (MA) hastalarda HBS prevalansı, HBS semptomlarının yaygınlığı ve bu semptomların etkileri, uygulanan tedaviler ve ferritinin HBS üzerine olan etkilerini araştırmak.Materyal ve metod: Başağrısı polikliniğinde, gerilim tipi başağrısı tanısı konan; 32 demir eksikliği anemili, 24 megaloblastik anemili ve kontrol grubu olarak gerilim tipi başağrısı olan fakat anemisi olmayan 20 olgu çalışmaya alındı. Tüm olgular HBS tanı kriterlerine göre değerlendirildi.Sonuçlar: HBS prevalansı; DEA'de % 12.5, MA'de %8.03 ve kontrol gurubunda %5 olarak saptandı. Tüm katılımcılarda HBS görülme sıklığı %7,7 olarak bulundu.Tartışma: Huzursuz Bacak Sendromu, kadınlarda ve yaş ilerledikçe daha fazla görülen bir hastalıktır. Demir metabolizmasının regülasyonundaki değişiklikler HBS'nin ortaya çıkmasına katkıda bulunmaktadır.

🔖

Cite This Article

YILMAZ, N. Ç., GENCER, M., TİRELİ, H., ÇETİNKAYA, Y., TÜRKOĞLU, R. (2022). Gerilim tipi baş ağrısı olan anemili hastalar ile huzursuz bacak sendromu birlikteliğinin araştırılması. Journal of Neurological Sciences (Turkish), Cilt: 26 - Sayı: 3, 305–310. https://ajindex.com/articles/565499

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Allen RP, Early CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-147
  2. Berger K. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164(2):196- 202
  3. Carskadon MA. Evaluation of excessive daytime sleepiness. Neurophysiol Clin 1993;23:91–100
  4. Claudia Trenkalder, Walter Paulus, Arthur S Walters. Restless Legs syndrome. Lancet Neurol 2005; 4: 465-475
  5. Cuellar NG, Ratcliffe SJ. A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome.J Clin Sleep Med. 2008 Feb 15;4(1):50-6 6) Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700
  6. Headache Classification Subcommittee of the International Headache Society. In: The international classification of headache disorders, 2nd ed.Cephalalgia, 2004;24(suppl 1):1–160
  7. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-24
  8. Page RL 2nd, Ruscin JM, Bainbridge JL, et al. Restless legs syndrome induced by escitalopram: case report and review of the literature. Pharmacotherapy 10) Peres MF,Stiles MA, Siow HC, et al. Excessive daytime Sleepiness in migraine patients. J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1467-8
  9. Phillips B, Youn T, et al. Epidemiology of restless legs symptoms in adul ts. Arch Intern Med 2000;160(14):2137- 2141
  10. Rhode AM,Hösing VG,Happe S,et al. Comorbidity of migraine and restless legs syndrome--a case-control Study.Cephalalgia. 2007 Nov;27(11):1255-60. Epub 2007 13) Richard P. Allen, Arthur S, et al. Restless Legs syndrome Prevelans and Impact. REST General Population Study. Archives of Internal Medicine. 2005; vol165, 1286-1292
  11. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and morbidity in augsburg elderly. Neurology 2000;54:1064-1068
  12. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey Neurology 2003;61:1562-69
  13. S.K. Weiland, Iron metabolism and the risk of Restless Legs Syndrome in an erderly general population.The MEMO study, J Neurol, 2002, 249; 1195-1199 17) S